IL1B and systemic-onset juvenile idiopathic arthritis: These immunologic features, together with the therapeutic efficacy of inhibitors of IL-1 or IL-6 in SJIA and AOSD, suggest that these diseases might be best classified as autoinflammatory rather than autoimmune [14-17].